Introduction
============

Nosocomial pneumonia is an important cause of morbidity and mortality in hospitalized patients. Diagnosis and treatment continues to challenge clinicians and stimulate investigators. Prevention of this serious infection has been the focus of numerous studies, conferences and professional documents. Nosocomial pneumonia prevention strategies may be directed at the ventilator circuit (frequency of tubing circuit changes and gas humidification strategies), the endotracheal tube (intubation orifice, secretion drainage and suctioning) or body position (kinetic bed therapy and semirecumbancy). Other nonpulmonary approaches are pharmacologic (selective digestive decontamination and stress ulcer prophylaxis) or nutritional (the type, site and timing of enteral feeds).

The largest number of published randomized trials in intensive care medicine have evaluated selective digestive decontamination and stress ulcer prophylaxis. Five meta-analyses \[[@B1],[@B2],[@B3],[@B4],[@B5]\] suggest that selective digestive decontamination confers a large, clinically important and statistically significant reduction in nosocomial pneumonia rates (common odds ratio approximately 0.30, 95% CI 0.28--0.48). Nevertheless, selective digestive decontamination is not widely used, in part due to concern about long-term microbial resistance patterns and antibiotic costs \[[@B6]\]. Stress ulcer prophylaxis trials have been recently summarized in a meta-analysis suggesting that sucralfate, as compared with histamine-2-receptor antagonists or antacids, is associated with a trend toward a lower rate of nosocomial pneumonia (common odds ratio 0.78, 95% CI 0.60--1.01) \[[@B7]\]. Other experiments show that modifying gastric pH with acidified enteral feeds decreases gastric colonization, thereby supporting this underlying biologic rationale \[[@B8]\]. However, sucralfate is not considered of proven benefit due to the possibility that sucralfate confers a protective effect only when compared with gastric pH-altering drugs (which themselves are associated with a modest increase in nosocomial pneumonia compared to control) \[[@B7]\].

Kinetic bed therapy has been reviewed in a meta-analysis of six trials in seriously and critically ill patients, which indicated a significantly lower rate of pneumonia and atelectasis in patients receiving continuous postural oscillation \[[@B9]\]. A less expensive and adaptable pneumonia prevention strategy focussing on body position has been studied in three randomized trials \[[@B10],[@B11],[@B12]\]. Torres *et al* \[[@B10]\] found that after instillation of radioactive technetium sulfur colloid into the stomach, radioactive counts in endobronchial secretions were significantly higher in samples obtained while patients were supine than when they were semirecumbent. In another study, scintigraphic evidence of esophageal reflux was found in 81% of patients in the supine position compared to 64% in the semirecumbent position \[[@B11]\]. Orozco-Levi *et al* administered nasogastric technetium sulfur colloid and found that radioactive counts in endobronchial secretions increased over time, but were higher in the supine than the semirecumbent position \[[@B12]\]. Although a causal relationship between pneumonia and this secondary endpoint of aspiration of gastric contents has not been convincingly demonstrated, these trials are in keeping with the gastropulmonary route of infection.

The gastropulmonary route of infection is a concept at least two decades old \[[@B13]\], support for which is derived from multiple human observational studies and experimental evidence \[[@B14], [@B15]\]. Enteral nutrition, compared to parenteral nutrition, is associated with decreased translocation in animals and decreased infectious morbidity in critical illness in humans \[[@B16]\]. Accordingly, it holds the promise of affording protection against nosocomial pneumonia. However, enterally feeding critically ill patients is often associated with intolerance, thereby predisposing them to aspiration pneumonia. The goal of this systematic review is to critically appraise and summarize the randomized trials of nutritional strategies and their influence on nosocomial pneumonia in critically ill patients.

Methods
=======

Study identification
--------------------

To identify randomized trials, we searched two computerized databases from 1980 onwards. For MEDLINE, we used the following text words and keywords: critical care, intensive care units, pneumonia, respiratory tract infection, mechanical ventilation, gastropulmonary, enteral nutrition, randomized controlled trials, prospective studies. For EMBASE, we used: pneumonia, prevention, control. Frequently cited articles were identified and SCISEARCH (Science Citation Index online) was used to locate any additional relevant randomized trials. We also used the Cochrane Library, searching the Clinical Trials Registry for randomized trials, and the Cochrane Database of Systematic Reviews (CDSR) as well as the Database of Abstracts of Reviews (DARE) for systematic reviews containing relevant primary studies. We confined our search to studies enrolling non-neutropenic adult humans without the human immunodeficiency virus. We had no language restrictions.

The titles (and the abstracts, when available) in the MEDLINE and EMBASE printouts, and the reference lists of all primary and review articles were reviewed independently in duplicate. Any additional relevant articles were thereby identified and retrieved.

Study selection
---------------

The following selection criteria were applied to the full manuscripts by two reviewers independently:

1\. Population: critically ill adults, including trauma and burn patients.

2\. Interventions: nutritional support.

3\. Outcomes: nosocomial pneumonia.

4\. Design: published randomized trials in humans.

*A priori*, we excluded relevant nutritional interventions in seriously but not necessarily critically ill patients, studies examining surrogate endpoints for pneumonia \[[@B8]\], studies which did not report how pneumonia was diagnosed \[[@B17],[@B18],[@B19]\], studies which evaluated or reported composite infectious outcomes \[[@B20]\], and duplicate publications \[[@B21]\].

Study characteristics and data abstraction
------------------------------------------

Two reviewers abstracted data from the randomized trials to describe the method of treatment allocation, the proportion of patients who were excluded post-randomization, whether cointerventions were described, whether the endpoints were assessed by investigators blinded to the intervention, and the outcome definitions employed. Disagreements between reviewers on design characteristics and raw data abstraction were resolved by discussion and consensus.

Analysis
--------

We measured agreement between reviewers on the selection of articles for inclusion in the review. We standardized presentation of the randomized trial results using relative risk, and calculated 95% confidence intervals using the log transformation method. Since study questions and trial designs differed, we did not statistically pool results of these trials, or subgroups of them, in a meta-analysis.

Results
=======

Study identification and selection
----------------------------------

The search yielded four trials of enteral *vs* total parenteral nutrition \[[@B22],[@B23],[@B24],[@B25]\], one trial of early enteral nutrition *vs* delayed enteral nutrition \[[@B26]\], one trial of gastric *vs* jejunal tube feeding \[[@B27]\], one trial of intermittent *vs* continuous enteral feeding \[[@B28]\], and three trials evaluating different enteral feeding formulae \[[@B29],[@B30],[@B31]\]. Agreement was 100% for selection of these trials and systematic reviews.

Study characteristics
---------------------

Study characteristics are reported in Table [1](#T1){ref-type="table"}. Patients were medical or surgical ICU patients, burn, or trauma victims. Two studies were explicit about concealment of randomization using sealed envelopes \[[@B26],[@B28]\]. The nature of some of these comparisons precluded blinding of patients and caregivers. Patients were unlikely to be aware of the details of their care and were not participating in assessment of the presence of nosocomial pneumonia. However, lack of blinding could have affected the care delivered by bedside nurses, respiratory therapists and intensivists, which could have affected the development of lung infection. In one trial, the neurosurgeon evaluating outcomes was blinded \[[@B22]\]; in another, confirmation of outcome was conducted by a second blinded surgeon \[[@B24]\]. Two of the three studies comparing different feeding products employed blinded outcome assessment \[[@B29],[@B31]\].

Cointerventions are interventions which are unrelated to the study question, yet may impact on the outcome, and could be unequally distributed across groups. These include stress ulcer prophylaxis and selective digestive decontamination (Table [1](#T1){ref-type="table"}). Other cointerventions not mentioned, but potentially important to standardize or report, might include chest physiotherapy and position of the patients.

In two trials, the pneumonia definition incorporated but did not require invasive bronchoscopic techniques \[[@B24],[@B28]\]; in a third trial, a positive bronchoalveolar lavage was required for the diagnosis \[[@B31]\].

Study results
-------------

The results of these randomized trials are presented in Table [2](#T2){ref-type="table"}. The four trials evaluating total parenteral *vs* enteral nutrition yield inconsistent results. In one, there was a trend toward a lower rate of pneumonia associated with enteral nutrition \[[@B23]\], in another study the pneumonia rate was significantly lower in the enteral nutrition group \[[@B24]\], and in the remaining two studies, the pneumonia rate was slightly higher in patients receiving enteral nutrition \[[@B22],[@B25]\].

One study examined early enteral nasoduodenal nutrition begun within 24 h *vs* nasoduodenal enteral nutrition delayed for 72 h. In patients receiving early feeds, there was a trend toward increased pneumonia (8/19 *vs* 4/19, respectively) \[[@B26]\].

Considering the potential for enteral nutrition to cause aspiration pneumonia, one study tested the effect of proximal *vs* distal delivery sites \[[@B27]\]. Two cases of pneumonia were identified amongst those 19 patients receiving prepyloric gastric feeds and no cases were observed in the 19 patients receiving post-pyloric feeds through a jejunal tube.

To avoid continuous alkalinization and intragastric Gram-negative growth associated with enteral feeding, intermittent enteral nutrition was compared with continuous enteral nutrition in one trial \[[@B28]\]. Five of 30 patients in each group developed nosocomial pneumonia.

Three studies examined different enteral feeding formulae and their relation to lung infection. The first compared modular tube feeds (a high protein, low fat, linoleic acid-restricted formulation enhanced with arginine, cysteine, vitamin A, zinc, omega-3-polyunsaturated fatty acids, and ascorbic acid) against Osmolite and Traumacal and found a trend toward lower pneumonia rates in the modular tube feed patients \[[@B29]\]. There was no difference in pneumonia between trauma patients fed Immun-Aid (containing glutamine, arginine, omega-3-polyunsaturated fatty acids, nucleotides, and branched chain amino-acids) *vs* Vivonex (standard enteral formulae) \[[@B30]\]. In another study of trauma patients, Immun-Aid was associated with a trend toward a lower pneumonia rate than patients fed with Promote (an isonitrogenous, isocaloric diet) \[[@B31]\].

###### 

Nutrition and nosocomial pneumonia: study characteristics

  Author \[reference\]              Intervention           Population            Allocation             Cointerventions          Exclusion post-        Blinding of        Definition of
  --------------------------------- ---------------------- --------------------- ---------------------- ------------------------ ---------------------- ------------------ -----------------------
  Young *et al* \[[@B22]\]          Nasogastric            Head injury           \`Was randomly         All patients received    7 Exclusions:          Neurosurgen        Infiltrate and
                                    enteral nutrition      patients              assigned to\'          prokinetic               5-early death, 2       evaluating         leukocytosis
                                    *vs* total                                                                                   -withdrew              outcomes was       premature cells,
                                    parenteral                                                                                                          blinded            fever, positive
                                    nutrition                                                                                                                              sputum culture
                                                                                                                                                                           
                                                                                                                                                                           
  Moore *et al* \[[@B23]\]          Enteral nutrition      Trauma patients       \`Randomized by        Broad spectrum           No exclusions:         Outcome            New infiltrate and
                                    via needle             requiring             computer               antibiotics to both      4-early death,         assessment not     fever, leukocytosis
                                    catheter               emergency             assignment\'           groups                   3-reoperation,         blinded            and purulent
                                    jejunostomy *vs*       celiotomy                                                             3-chronic illness,                        sputum
                                    total parenteral                                                                             2-ATI\> 40,                               
                                    nutrition                                                                                    2-head injury,                            
                                                                                                                                 1-mechanical                              
                                                                                                                                 failure,                                  
                                                                                                                                 1-transfer                                
                                                                                                                                                                           
                                                                                                                                                                           
  Kudsk *et al* \[[@B24]\]          Enteral nutrition      Patients with blunt   \`Computer             NR                       2 Exclusions:          Secondary          New infiltrate and
                                    via needle             and penetrating       generated                                       death within 4         confirmation of    leukocytosis,
                                    jejunostomy *vs*       abdominal trauma      randomization                                   days                   outcome by         positive sputum or
                                    total parenteral                             table\'                                                                blinded surgeon    BAL, or purulent
                                    nutrition                                                                                                                              sputum
                                                                                                                                                                           
                                                                                                                                                                           
  Borzotta *et al* \[[@B25]\]       Enteral nutrition      Patients with         \`Computer             Jejunostomy group        NR                     Outcome            Infiltrate and
                                    via needle             severe closed head    generated random       had gastrostomy                                 assessment not     fever, leukocytosis,
                                    catheter               injury                number                 tube drainage                                   blinded            leukorrhea and
                                    jejunostomy *vs*                             assignment\'                                                                              bacteria on Gram
                                    total parenteral                                                                                                                       stain
                                    nutrition                                                                                                                              
                                                                                                                                                                           
                                                                                                                                                                           
  Eyer *et al* \[[@B26]\]           Early (\<24 h)         Patients with blunt   \`Randomization by     All patients received    14 Exclusions:         Outcome            New infiltrate and
                                    nasoduodenal           abdominal trauma      card drawn from        either sucralfate or     3-regular diet,        assessment not     significant growth
                                    tube feeding *vs*                            sealed envelope\'      antacids but group not   3-steroids,            blinded            on sputum
                                    late (\>72 h)                                                       specified                2-no NGT,                                 culture with \<10
                                    nasoduodenal                                                                                 6-miscellaneous                           epithelial cells,
                                    tube feeding                                                                                                                           \>25 wbc/hpf OR
                                                                                                                                                                           purulent
                                                                                                                                                                           secretions, fever
                                                                                                                                                                           and leukocytosis
                                                                                                                                                                           
                                                                                                                                                                           
  Montecalvo *et al* \[[@B27]\]     Gastric *vs* jejunal   Medical and           \`Randomly             25 Patients received     5 Patients crossed     Cultures           New and
                                    tube feeding           surgical ICU          assigned               sucralfate; 1 H~2~RA;    over from jejunal to   reviewed blinded   persistent
                                                           patients              according to           2 H~2~RA and antacids;   gastric group and      to group           infiltrate and
                                                                                 computer               8 sucralfate and         2 patients crossed     assignment         three of: purulent
                                                                                 generated random       either H~2~RA or         over from gastric                         sputum with
                                                                                 number code\'          antacids; 1 no stress    to jejunal group;                         numerous
                                                                                                        ulcer prophylaxis, but   these 7 patients                          bacteria, purulent
                                                                                                        group not specified      were included until                       sputum with
                                                                                                                                 the day they                              nosocomial
                                                                                                                                 crossed over                              pathogen, T\>38^6^,
                                                                                                                                                                           or wbc \>10
                                                                                                                                                                           
                                                                                                                                                                           
  Bonten *et al* \[[@B28]\]         Intermittent           Mixed ICU             \`Randomization        Intermittent: 13-        None                   Outcome            New and
                                    enteral feeding        patients and          was performed          antacids and 17-                                assessment not     persistent
                                    (18 h) *vs*            cardiac surgery       with sealed            sucralfate;                                     blinded            infiltrate and 3 of:
                                    continuous             patients needing      envelopes\'            continuous: 7 -                                                    T\>38 or T\<35^5^
                                    enteral feeding        ventilation \> 3                             antacids and 23 -                                                  OR wbc \> 10
                                    (24 h)                 days                                         sucralfate                                                         and/or left shift
                                                                                                                                                                           or wbc \< 3 OR 10
                                                                                                                                                                           wbc/hpf on ET
                                                                                                                                                                           Gram strain OR
                                                                                                                                                                           positive ET
                                                                                                                                                                           aspirate and one
                                                                                                                                                                           of these: BAL
                                                                                                                                                                           (positive if \> 10^4^
                                                                                                                                                                           CFU/ml) OR
                                                                                                                                                                           PSB (positive if
                                                                                                                                                                           \>10^3^ CFU/ml)
                                                                                                                                                                           OR positive
                                                                                                                                                                           blood culture OR
                                                                                                                                                                           positive pleural
                                                                                                                                                                           culture
                                                                                                                                                                           
                                                                                                                                                                           
  Gottsschlich *et al* \[[@B29]\]   Modular tube           Burn patients         \`Random number        NR                       NR                     Physicians,        Infiltrate and
                                    feeding *vs* two       (\>10% BSA)           table stratified for                                                   nurses,            positive sputum
                                    standard enteral                             age, center and                                                        technicians,       culture and
                                    feeding                                      burn size\'                                                            clinical and       systemic
                                    (Osmolite *vs*                                                                                                      research           antibotics
                                    Traumacal)                                                                                                          personnel were     
                                                                                                                                                        blinded            
                                                                                                                                                                           
                                                                                                                                                                           
  Moore *et al* \[[@B30]\]          Early enteral          Trauma patients       \`Randomized by a      NR                       16 exclusions:         Outcome            New and
                                    immune-                                      computer-                                       9-inappropriate        assessment not     progressive
                                    enhancing                                    generated                                       randomizations,        blinded            infiltrate, fever,
                                    feeding *vs*                                 schedule\'                                      7-drop -outs                              leukocytosis,
                                    standard enteral                                                                             1-early death                             positive sputum
                                    feeding                                                                                                                                Gram stain with
                                    (Vivonex)                                                                                                                              many polys
                                                                                                                                                                           
                                                                                                                                                                           
  Kudsk *et al* \[[@B31]\]          Early immune-          Trauma patients       \`Computer-            Short-term broad         NR                     All caregivers     New or changing
                                    enhancing              requiring             generated              spectrum antibiotics                            blinded except     infiltrate and
                                    feeding via            emergency             randomization          to both groups                                  nutritionist       fever,
                                    jejunostomy *vs*       celiotomy             table\'                                                                                   leukocytosis,
                                    standard enteral                                                                                                                       purulent sputum
                                    feeding                                                                                                                                underwent BAL
                                    (Promote)                                                                                                                              (positive if \> 10^3^
                                                                                                                                                                           CFU/hpf)

*Abbreviations:* ATI=acute trauma index; BAL=bronchoalveolar lavage; NGT=nasogastric tube; wbc=white blood cells; hpf=high power field; H~2~RA=histamine-2-receptor antagonists; ET=endotracheal; CFU=colony forming units; BSA=body surface area; NR=not reported; VAP=ventilator-associated pneumonia; PSB=protected specimen brush.

###### 

Results of randomized trails of nutrition and nosocomial pneumonia

  Intervention (author \[reference\])                                                Pneumonia rates         Relative risk (95% Cl)               
  ---------------------------------------------------------------------------------- ----------------------- ------------------------ -- -- -- -- --
  Nasogastric enteral nutrition *vs* parenteral nutrition (Young \[[@B22]\])         TPN: 6/23 (26%)         1.23 (0.51--2.95)                    
                                                                                     EN: 9/28 (32%)                                               
                                                                                                                                                  
                                                                                                                                                  
  Jejunostomy feeding *vs* total parenteral nutrition (Moore \[[@B23]\])             TPN: 6/30 (20%)         Undefined                            
                                                                                     EN: 0/29 (0%)                                                
                                                                                                                                                  
                                                                                                                                                  
  Jejunostomy feeding *vs* total parenteral nutrition (Kudsk \[[@B24]\])             TPN: 14/45 (31%)        0.38 (0.16--0.90)                    
                                                                                     EN: 6/51 (12%)                                               
                                                                                                                                                  
                                                                                                                                                  
  Jejunostomy feeding *vs* total parenteral nutrition (Borzotta \[[@B25]\])          TPN: 9/23 (39%)         1.06 (0.56--2.02)                    
                                                                                     EN: 15/36 (42%)                                              
                                                                                                                                                  
                                                                                                                                                  
  Early nasoduodenal *vs* late nasoduodenal feeding (Eyer \[[@B26]\])                Late: 4/19 (21%)        2.00 (0.72--5.54)                    
                                                                                     Early: 8/19 (42%)                                            
                                                                                                                                                  
                                                                                                                                                  
  Jejunal *vs* gastric feeding (Montecalvo \[[@B27]\])                               Gastric: 2/19 (11%)     Undefined                            
                                                                                     Jejunal: 0/19 (0%)                                           
                                                                                                                                                  
                                                                                                                                                  
  Intermittent enteral feeding *vs* continuous enteral feeding (Bonten \[[@B28]\])   CEF: 5/30 (17%)         1.0 (0.32--3.10)                     
                                                                                     IEF: 5/30 (17%)                                              
                                                                                                                                                  
                                                                                                                                                  
  Modular tube feeding (MTF) *vs* Osmolite *vs* Traumacal (Gottschlich \[[@B29]\])   Osmolite: 6/14 (43%)    0.27 (0.07--1.15)^\*^                
                                                                                     Traumacal: 9/19 (47%)   0.25 (0.06-0.99)^†^                  
                                                                                     MTF: 2/17 (12%)                                              
                                                                                                                                                  
                                                                                                                                                  
  Immun-Aid *vs* Vivonex (Moore \[[@B30]\])                                          Vivonex: 4/47 (9%)      0.92 (0.24--3.48)                    
                                                                                     Immun-Aid: 4/51 (8%)                                         
                                                                                                                                                  
                                                                                                                                                  
  Immun-Aid *vs* Promote (Kudsk \[[@B31]\])                                          Promote: 3/17 (18%)     Undefined                            
                                                                                     Immun-Aid: 0/16 (0%)                                         

*Abbreviations*: EN = enteral nutrition; TPN = total parenteral nutrition; CEF = continuous enteral feeding; IEF = intermittent enteral feeding. ^\*^ Osmolite compared to MTF. ^†^ Traumacal compared to MTF.

Discussion
==========

The results of these 10 trials of feeding strategies, either individually or in aggregate, provide inconclusive evidence about the relation between enteral nutrition and nosocomial pneumonia. These studies enrolled a total of 582 patients and contribute 117 cases of pneumonia. The single trial showing a significantly lower pneumonia rate associated with jejunal enteral nutrition over parenteral nutrition \[[@B24]\] has not been translated into widespread clinical policy, perhaps due to the inconvenience and expertise required for jejunostomy tubes. Aside from concerns about type I and II error when interpreting the trials in this review, there are other relevant outcomes addressed by some, but not all of these studies, including effects on nutritional markers and adverse outcomes such as catheter sepsis and patient comfort. Readers are referred to the original articles for these important details.

Factors such as cost, and ease with which the feeding strategy can be employed, are additional issues that bear on the interpretation and application of these trial results in practice. Intensivists also consider evidence from observational studies when making clinical decisions. Given these provisos, it is not surprising that definitive statements about enteral nutrition and lung infection are not forthcoming. Some guidelines from the Center for Disease Control on the prevention of nosocomial pneumonia \[[@B32]\] focus on gastropulmonary approaches. Stress ulcer prophylaxis with an agent that does not increase gastric pH was \`suggested for implementation in many hospitals and supported by suggestive clinical and epidemiologic studies and a strong theoretical rationale\'. Other interventions labelled as \`unresolved for which no recommendations were made\' included jejunal feeding, intermittent enteral feeding and selective digestive decontamination. In the American Thoracic Society statement on prevention of hospital-acquired pneumonia in adults \[[@B33]\], some prophylactic interventions were classified as having \`probable effectiveness, used widely in some clinical settings\', such as distal enteral nutrition, semi-erect positioning, and sucralfate. Selective digestive decontamination was considered \`of unproven value used on a limited investigational or clinical basis\'.

Nutrition is integral to the care of an ICU patient. The method, site and timing of enteral nutrition may have a protective or predisposing influence on the risk of nosocomial infection \[[@B34]\], though strong proof from experiments in humans does not currently exist. Although a meta-analysis of published and unpublished trials of general surgical and trauma patients suggested a lower pneumonia rate in patients receiving enteral nutrition *vs* total parenteral nutrition \[[@B35]\], published data from ventilated medical ICU patients are sparse, and generalizing to other populations may not be reasonable. Interventions requiring further investigation with large rigorous studies of ICU patients include those discussed in this review, as well as the size of feeding tubes \[[@B36]\], their insertion site, where the tubes are located in the gastrointestinal tract \[[@B37]\], feeding advancement schedules, and the effect of prokinetic drugs \[[@B38]\].
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